Assessment of durable chemoimmunotherapy response via circulating tumor DNA in advanced esophageal squamous cell carcinoma

Immune checkpoint inhibitor (ICI)‐based therapies have shown promising advances for the first‐line treatment of advanced or metastatic esophageal cancer (EC). However, few studies concerning the identification of patients who achieve durable response from ICIs have been previously reported. In the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Dongyang, Xu, Fei, Li, Ying, Lai, Xiaorong, Xian, Bohong, Yu, Pengli, Chen, Rongrong, Li, Zijun, Ma, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527169/
https://www.ncbi.nlm.nih.gov/pubmed/35997004
http://dx.doi.org/10.1111/1759-7714.14610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527169/
https://www.ncbi.nlm.nih.gov/pubmed/35997004
http://dx.doi.org/10.1111/1759-7714.14610

Ejemplares similares